KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Net Income (2016 - 2025)

Historic Net Income for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $1.6 billion.

  • Abbott Laboratories' Net Income fell 12.15% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $14.0 billion, marking a year-over-year increase of 14236.17%. This contributed to the annual value of $13.4 billion for FY2024, which is 13417.79% up from last year.
  • As of Q3 2025, Abbott Laboratories' Net Income stood at $1.6 billion, which was down 12.15% from $1.8 billion recorded in Q2 2025.
  • Over the past 5 years, Abbott Laboratories' Net Income peaked at $9.2 billion during Q4 2024, and registered a low of $1.0 billion during Q4 2022.
  • For the 5-year period, Abbott Laboratories' Net Income averaged around $2.0 billion, with its median value being $1.6 billion (2023).
  • As far as peak fluctuations go, Abbott Laboratories' Net Income soared by 4962500.0% in 2021, and later plummeted by 4806.44% in 2022.
  • Quarter analysis of 5 years shows Abbott Laboratories' Net Income stood at $2.0 billion in 2021, then tumbled by 48.06% to $1.0 billion in 2022, then soared by 54.31% to $1.6 billion in 2023, then soared by 478.98% to $9.2 billion in 2024, then tumbled by 82.19% to $1.6 billion in 2025.
  • Its Net Income was $1.6 billion in Q3 2025, compared to $1.8 billion in Q2 2025 and $1.3 billion in Q1 2025.